Marks Group Wealth Management Inc Trims Stock Holdings in Maximus, Inc. (NYSE:MMS)

Marks Group Wealth Management Inc trimmed its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 58.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 36,030 shares of the health services provider's stock after selling 51,296 shares during the period. Marks Group Wealth Management Inc owned 0.06% of Maximus worth $3,021,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in MMS. SG Americas Securities LLC acquired a new stake in Maximus in the 3rd quarter worth about $2,262,000. GHP Investment Advisors Inc. boosted its stake in Maximus by 3.9% in the 3rd quarter. GHP Investment Advisors Inc. now owns 27,193 shares of the health services provider's stock worth $2,090,000 after buying an additional 1,025 shares during the last quarter. HGK Asset Management Inc. raised its holdings in shares of Maximus by 11.8% in the 3rd quarter. HGK Asset Management Inc. now owns 7,395 shares of the health services provider's stock worth $552,000 after purchasing an additional 782 shares during the period. Cavalier Investments LLC raised its holdings in shares of Maximus by 3.8% in the 3rd quarter. Cavalier Investments LLC now owns 19,200 shares of the health services provider's stock worth $1,434,000 after purchasing an additional 699 shares during the period. Finally, Reinhart Partners LLC. raised its holdings in shares of Maximus by 1.6% in the 3rd quarter. Reinhart Partners LLC. now owns 209,244 shares of the health services provider's stock worth $15,626,000 after purchasing an additional 3,238 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Down 0.2 %

MMS stock traded down $0.16 during midday trading on Wednesday, hitting $80.82. 216,966 shares of the company's stock were exchanged, compared to its average volume of 335,095. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.71. Maximus, Inc. has a 12-month low of $72.39 and a 12-month high of $89.69. The firm has a 50 day moving average price of $82.63 and a 200-day moving average price of $81.30. The stock has a market capitalization of $4.93 billion, a price-to-earnings ratio of 26.76 and a beta of 0.72.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, topping the consensus estimate of $1.28 by $0.06. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The business's revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.94 EPS. On average, analysts anticipate that Maximus, Inc. will post 5.41 EPS for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be given a $0.30 dividend. The ex-dividend date is Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.48%. Maximus's payout ratio is 39.74%.

Insider Transactions at Maximus

In other news, CFO David Mutryn sold 8,000 shares of Maximus stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the transaction, the chief financial officer now owns 5,124 shares in the company, valued at approximately $430,159.80. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 1.40% of the company's stock.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of research reports. StockNews.com upgraded Maximus from a "hold" rating to a "buy" rating in a report on Thursday, February 8th. Raymond James downgraded Maximus from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 3rd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.